The report outlines Takeda's financial and non-financial results for fiscal year 2020, demonstrating the company's commitment to patients, people, and the planet. It highlights the completion of the Shire integration, the company's strong performance in its five key business areas, and its commitment to sustainable growth through responsible innovation. The report also outlines Takeda's response to the COVID-19 pandemic, including its collaborations on vaccine development, its support for clinical trials, and its efforts to ensure uninterrupted supply of medicines.
Issuing Company Takeda Pharmaceutical Co., Ltd.
Report Type Integrated Report
Report Language EN
Report Filesize 11.03 MB
No. of Pages 101 pages
Reporting periodApril 1, 2020 to March 31, 2021
Report EditionUnknown
Assurance Provider Unknown
Reporting Standards GRI; SASB; UNSDGs
Materiality Assessmenttrue